381 related articles for article (PubMed ID: 24396627)
1. Cytomegalovirus infections in solid organ transplantation: a review.
Ramanan P; Razonable RR
Infect Chemother; 2013 Sep; 45(3):260-71. PubMed ID: 24396627
[TBL] [Abstract][Full Text] [Related]
2. New developments in the management of cytomegalovirus infection after solid organ transplantation.
Eid AJ; Razonable RR
Drugs; 2010 May; 70(8):965-81. PubMed ID: 20481654
[TBL] [Abstract][Full Text] [Related]
3. Cytomegalovirus infection after liver transplantation: current concepts and challenges.
Razonable RR
World J Gastroenterol; 2008 Aug; 14(31):4849-60. PubMed ID: 18756591
[TBL] [Abstract][Full Text] [Related]
4. Epidemiology of cytomegalovirus disease in solid organ and hematopoietic stem cell transplant recipients.
Razonable RR
Am J Health Syst Pharm; 2005 Apr; 62(8 Suppl 1):S7-13. PubMed ID: 15821266
[TBL] [Abstract][Full Text] [Related]
5. Effect of Preemptive Therapy vs Antiviral Prophylaxis on Cytomegalovirus Disease in Seronegative Liver Transplant Recipients With Seropositive Donors: A Randomized Clinical Trial.
Singh N; Winston DJ; Razonable RR; Lyon GM; Silveira FP; Wagener MM; Stevens-Ayers T; Edmison B; Boeckh M; Limaye AP
JAMA; 2020 Apr; 323(14):1378-1387. PubMed ID: 32286644
[TBL] [Abstract][Full Text] [Related]
6. Clinical utility of cytomegalovirus viral load in solid organ transplant recipients.
Dioverti MV; Razonable RR
Curr Opin Infect Dis; 2015 Aug; 28(4):317-22. PubMed ID: 26098497
[TBL] [Abstract][Full Text] [Related]
7. Cytomegalovirus viraemia and mortality in renal transplant recipients in the era of antiviral prophylaxis. Lessons from the western Australian experience.
Selvey LA; Lim WH; Boan P; Swaminathan R; Slimings C; Harrison AE; Chakera A
BMC Infect Dis; 2017 Jul; 17(1):501. PubMed ID: 28716027
[TBL] [Abstract][Full Text] [Related]
8. Clinical utility of viral load in management of cytomegalovirus infection after solid organ transplantation.
Razonable RR; Hayden RT
Clin Microbiol Rev; 2013 Oct; 26(4):703-27. PubMed ID: 24092851
[TBL] [Abstract][Full Text] [Related]
9. Cytomegalovirus infection in solid organ transplant recipients: new challenges and their implications for preventive strategies.
Singh N
J Clin Virol; 2006 Apr; 35(4):474-7. PubMed ID: 16406798
[TBL] [Abstract][Full Text] [Related]
10. Prevention and management of CMV infection in pediatric solid organ transplant recipients.
Balani SS; Sadiq S; Jensen CJ; Kizilbash SJ
Front Pediatr; 2023; 11():1098434. PubMed ID: 36891229
[TBL] [Abstract][Full Text] [Related]
11. Strategies for managing cytomegalovirus in transplant recipients.
Razonable RR
Expert Opin Pharmacother; 2010 Aug; 11(12):1983-97. PubMed ID: 20642369
[TBL] [Abstract][Full Text] [Related]
12. Management of cytomegalovirus infection in solid organ transplantation.
Kotton CN
Nat Rev Nephrol; 2010 Dec; 6(12):711-21. PubMed ID: 20978468
[TBL] [Abstract][Full Text] [Related]
13. Pharmacologic and immunologic management of cytomegalovirus infection after solid organ and hematopoietic stem cell transplantation.
Meesing A; Razonable RR
Expert Rev Clin Pharmacol; 2018 Aug; 11(8):773-788. PubMed ID: 30009675
[TBL] [Abstract][Full Text] [Related]
14. Viral load, CMV-specific T-cell immune response and cytomegalovirus disease in solid organ transplant recipients at higher risk for cytomegalovirus infection during preemptive therapy.
Martín-Gandul C; Pérez-Romero P; Blanco-Lobo P; Benmarzouk-Hidalgo OJ; Sánchez M; Gentil MA; Bernal C; Sobrino JM; Rodríguez-Hernández MJ; Cordero E;
Transpl Int; 2014 Oct; 27(10):1060-8. PubMed ID: 24964364
[TBL] [Abstract][Full Text] [Related]
15. Prevention and treatment of cytomegalovirus infection in organ transplant recipients.
Kusne S; Shapiro R; Fung J
Transpl Infect Dis; 1999 Sep; 1(3):187-203. PubMed ID: 11428989
[TBL] [Abstract][Full Text] [Related]
16. Cytomegalovirus in solid organ transplant recipients-Guidelines of the American Society of Transplantation Infectious Diseases Community of Practice.
Razonable RR; Humar A
Clin Transplant; 2019 Sep; 33(9):e13512. PubMed ID: 30817026
[TBL] [Abstract][Full Text] [Related]
17. Clinical utility of molecular surveillance for cytomegalovirus after antiviral prophylaxis in high-risk solid organ transplant recipients.
Lisboa LF; Preiksaitis JK; Humar A; Kumar D
Transplantation; 2011 Nov; 92(9):1063-8. PubMed ID: 21878838
[TBL] [Abstract][Full Text] [Related]
18. High risk of cytomegalovirus infection following solid organ transplantation despite prophylactic therapy.
Harvala H; Stewart C; Muller K; Burns S; Marson L; MacGilchrist A; Johannessen I
J Med Virol; 2013 May; 85(5):893-8. PubMed ID: 23508914
[TBL] [Abstract][Full Text] [Related]
19. Prevention and Treatment of Cytomegalovirus Infections in Solid Organ Transplant Recipients.
Koval CE
Infect Dis Clin North Am; 2018 Sep; 32(3):581-597. PubMed ID: 30146024
[TBL] [Abstract][Full Text] [Related]
20. Management strategies for cytomegalovirus infection and disease in solid organ transplant recipients.
Razonable RR
Infect Dis Clin North Am; 2013 Jun; 27(2):317-42. PubMed ID: 23714343
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
